Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Avalo Therapeutics Price to Sales Ratio 2014-2024 | AVTX

Historical PS ratio values for Avalo Therapeutics (AVTX) over the last 10 years. The current P/S ratio for Avalo Therapeutics as of June 17, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Avalo Therapeutics P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-06-17 11.47 0.81
2024-03-31 21.75 $14.21 1.53
2023-12-31 9.10 $23.94 0.38
2023-09-30 28.97 $44.75 0.65
2023-06-30 85.25 $422.00 0.20
2023-03-31 420.00 $437.20 0.96
2022-12-31 1209.62 $457.16 2.65
2022-09-30 796.80 $440.59 1.81
2022-06-30 1440.00 $102.67 14.02
2022-03-31 2087.14 $176.08 11.85
2021-12-31 4896.00 $161.64 30.29
2021-09-30 6278.40 $219.56 28.60
2021-06-30 9417.60 $221.42 42.53
2021-03-31 8697.60 $182.69 47.61
2020-12-31 7603.20 $313.14 24.28
2020-09-30 6552.00 $287.66 22.78
2020-06-30 7488.00 $391.03 19.15
2020-03-31 7142.40 $423.00 16.89
2019-12-31 15523.20 $456.20 34.03
2019-09-30 9475.20 $-100.08 0.00
2019-06-30 15667.20 $90.90 172.35
2019-03-31 16819.20 $421.57 39.90
2018-12-31 9302.40 $650.18 14.31
2018-09-30 13449.60 $1,506.16 8.93
2018-06-30 12499.20 $4,507.74 2.77
2018-03-31 12355.20 $4,118.59 3.00
2017-12-31 9216.00 $3,817.78 2.41
2017-09-30 2448.29 $3,537.76 0.69
2017-06-30 1650.24 $303.12 5.44
2017-03-31 1944.29 $485.65 4.00
2016-12-31 2535.55 $378.93 6.69
2016-09-30 12182.40 $320.54 38.01
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.011B $0.002B
Avalo Therapeutics Inc. is a clinical-stage precision medicine company which discovers, develops and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology and rare genetic diseases. Avalo Therapeutics Inc., formerly known as Cerecor, is based in WAYNE, Pa.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.821B 31.64
Chugai Pharmaceutical (CHGCY) Japan $51.488B 23.01
Takeda Pharmaceutical (TAK) Japan $41.459B 8.40
Merck (MKGAF) Germany $24.092B 23.36
Astellas Pharma (ALPMY) Japan $17.210B 27.17
Sandoz Group AG (SDZNY) Switzerland $15.410B 0.00
Neurocrine Biosciences (NBIX) United States $13.631B 37.31
United Therapeutics (UTHR) United States $12.777B 13.62
Shionogi (SGIOY) Japan $11.322B 9.84
Catalent (CTLT) United States $10.041B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.567B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.118B 7.82
Revolution Medicines (RVMD) United States $6.372B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Ionis Pharmaceuticals (IONS) United States $5.933B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.916B 0.00
Summit Therapeutics (SMMT) United States $5.890B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.575B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.209B 0.00
Corcept Therapeutics (CORT) United States $3.016B 27.33
Dyne Therapeutics (DYN) United States $2.890B 0.00
PTC Therapeutics (PTCT) United States $2.747B 0.00
Indivior (INDV) United States $2.279B 10.80
Recursion Pharmaceuticals (RXRX) United States $2.201B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.127B 12.09
Catalyst Pharmaceuticals (CPRX) United States $1.779B 17.31
NewAmsterdam Pharma (NAMS) Netherlands $1.727B 0.00
Evotec AG (EVO) Germany $1.612B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.606B 24.14
Avadel Pharmaceuticals (AVDL) Ireland $1.520B 0.00
Ardelyx (ARDX) United States $1.478B 0.00
Soleno Therapeutics (SLNO) United States $1.417B 0.00
Pacira BioSciences (PCRX) United States $1.309B 12.45
BioCryst Pharmaceuticals (BCRX) United States $1.273B 0.00
Xencor (XNCR) United States $1.269B 0.00
4D Molecular Therapeutics (FDMT) United States $1.222B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.155B 0.00
Collegium Pharmaceutical (COLL) United States $1.039B 6.22
Centessa Pharmaceuticals (CNTA) United Kingdom $1.023B 0.00
Enliven Therapeutics (ELVN) United States $1.021B 0.00
Relay Therapeutics (RLAY) United States $0.970B 0.00
Cassava Sciences (SAVA) United States $0.946B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.913B 14.22
Cronos Group (CRON) Canada $0.909B 0.00
Ocular Therapeutix (OCUL) United States $0.891B 0.00
USANA Health Sciences (USNA) United States $0.857B 14.01
ARS Pharmaceuticals (SPRY) United States $0.839B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.806B 0.00
Sage Therapeutics (SAGE) United States $0.722B 0.00
Harrow (HROW) United States $0.636B 0.00
ProKidney (PROK) United States $0.626B 0.00
Exscientia (EXAI) United Kingdom $0.608B 0.00
Lyell Immunopharma (LYEL) United States $0.602B 0.00
Larimar Therapeutics (LRMR) United States $0.599B 0.00
Silence Therapeutics (SLN) United Kingdom $0.578B 0.00
Lexeo Therapeutics (LXEO) United States $0.573B 0.00
Esperion Therapeutics (ESPR) United States $0.566B 0.00
Savara (SVRA) United States $0.564B 0.00
Heron Therapeutics (HRTX) United States $0.542B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.535B 0.00
KalVista Pharmaceuticals (KALV) United States $0.509B 0.00
Bioventus (BVS) United States $0.505B 19.33
OmniAb (OABI) United States $0.496B 0.00
Siga Technologies (SIGA) United States $0.474B 6.06
Verve Therapeutics (VERV) United States $0.455B 0.00
Tourmaline Bio (TRML) United States $0.435B 0.00
Altimmune (ALT) United States $0.433B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.412B 0.00
Korro Bio (KRRO) United States $0.386B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.344B 0.00
Black Diamond Therapeutics (BDTX) United States $0.336B 0.00
Organogenesis (ORGO) United States $0.331B 62.38
Xeris Biopharma Holdings (XERS) United States $0.326B 0.00
Nature's Sunshine Products (NATR) United States $0.282B 17.91
Enanta Pharmaceuticals (ENTA) United States $0.272B 0.00
Fractyl Health (GUTS) United States $0.270B 0.00
Eliem Therapeutics (ELYM) United States $0.262B 0.00
Century Therapeutics (IPSC) United States $0.259B 0.00
Aquestive Therapeutics (AQST) United States $0.245B 0.00
ESSA Pharma (EPIX) Canada $0.238B 0.00
Akebia Therapeutics (AKBA) United States $0.224B 0.00
Acrivon Therapeutics (ACRV) United States $0.224B 0.00
Foghorn Therapeutics (FHTX) United States $0.224B 0.00
Pyxis Oncology (PYXS) United States $0.223B 0.00
Aldeyra Therapeutics (ALDX) United States $0.222B 0.00
Nanobiotix S.A (NBTX) France $0.217B 0.00
Avita Medical (RCEL) United States $0.216B 0.00
Nektar Therapeutics (NKTR) United States $0.215B 0.00
Prelude Therapeutics (PRLD) United States $0.214B 0.00
Incannex Healthcare (IXHL) Australia $0.211B 0.00
Metagenomi (MGX) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.202B 0.00
Innate Pharma SA (IPHYF) France $0.200B 0.00
Zevra Therapeutics (ZVRA) United States $0.195B 0.00
Adherex Technologies (FENC) United States $0.185B 225.33
Elite Pharmaceuticals (ELTP) United States $0.180B 16.84
Achieve Life Sciences (ACHV) Canada $0.168B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.167B 0.00
Cardiol Therapeutics (CRDL) Canada $0.165B 0.00
Telomir Pharmaceuticals (TELO) United States $0.163B 0.00
Galectin Therapeutics (GALT) United States $0.163B 0.00
Regulus Therapeutics (RGLS) United States $0.158B 0.00
Context Therapeutics (CNTX) United States $0.147B 0.00
MediWound (MDWD) Israel $0.139B 0.00
CytoDyn (CYDY) United States $0.133B 0.00
Conduit Pharmaceuticals (CDT) United States $0.133B 0.00
OptiNose (OPTN) United States $0.131B 0.00
Karyopharm Therapeutics (KPTI) United States $0.119B 0.00
Citius Pharmaceuticals (CTXR) United States $0.113B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.112B 7.45
Journey Medical (DERM) United States $0.111B 0.00
FibroGen (FGEN) United States $0.111B 0.00
VAXART, INC (VXRT) United States $0.101B 0.00
Assertio Holdings (ASRT) United States $0.100B 4.57
Relmada Therapeutics (RLMD) United States $0.091B 0.00
Vivani Medical (VANI) United States $0.088B 0.00
AlloVir (ALVR) United States $0.088B 0.00
ProPhase Labs (PRPH) United States $0.088B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
PMV Pharmaceuticals (PMVP) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.080B 0.00
SCYNEXIS (SCYX) United States $0.077B 1.09
Champions Oncology (CSBR) United States $0.068B 0.00
Tempest Therapeutics (TPST) United States $0.064B 0.00
Nutriband (NTRB) United States $0.059B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.055B 0.00
Mural Oncology (MURA) Ireland $0.055B 0.00
BioLineRx (BLRX) Israel $0.053B 0.00
Protara Therapeutics (TARA) United States $0.053B 0.00
DURECT (DRRX) United States $0.051B 0.00
Lipocine (LPCN) United States $0.051B 0.00
Carisma Therapeutics (CARM) United States $0.047B 0.00
Inotiv (NOTV) United States $0.046B 0.00
CASI Pharmaceuticals (CASI) China $0.042B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Surrozen (SRZN) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
VYNE Therapeutics (VYNE) United States $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.032B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
BioVie (BIVI) United States $0.028B 0.00
Viracta Therapeutics (VIRX) United States $0.026B 0.00
SHINECO (SISI) China $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Unicycive Therapeutics (UNCY) United States $0.024B 0.00
Aptorum Group (APM) United Kingdom $0.023B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
Minerva Neurosciences (NERV) United States $0.023B 0.00
Gain Therapeutics (GANX) United States $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
JanOne (JAN) United States $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.021B 0.00
PolyPid (PYPD) Israel $0.020B 0.00
Jaguar Animal Health (JAGX) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.019B 0.74
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Alaunos Therapeutics (TCRT) United States $0.015B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Plus Therapeutics (PSTV) United States $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 30.12